S. G. Ahmed, The role of infection in the pathogenesis of vaso-occlusive crisis in 652 patients with sickle cell disease, Mediterranean journal of hematology and infectious, vol.653, issue.1, p.2011028, 2011.

S. Akira, S. Uematsu, and O. (. Takeuchi, Pathogen recognition and innate immunity, Cell, vol.655, issue.4, pp.783-801, 2006.

A. Alter, . Grant, L. Abel, A. Alcaïs, and E. Schurr, Leprosy as a genetic disease, 2011.
DOI : 10.1007/s00335-010-9287-1

, Mammalian genome, vol.22, issue.1-2, pp.19-31

V. Bagheri, A. Askari, . Arababadi, . Mk, and D. Kennedy, Can Toll-Like Receptor (TLR) 2 659 be considered as a new target for immunotherapy against hepatitis B infection, 2014.
DOI : 10.1016/j.humimm.2014.02.018

, Human immunology, vol.75, issue.6, pp.549-554

R. Barbalat, L. Lau, R. M. Locksley, and G. M. Barton, Toll-like receptor 2 on inflammatory 662 monocytes induces type I interferon in response to viral but not bacterial ligands. 663, Nature immunology, vol.10, issue.11, pp.1200-1207, 2009.
DOI : 10.1038/ni.1792

URL : http://europepmc.org/articles/pmc2821672?pdf=render

J. M. Bland, . Altman, and . Dg, Multiple significance tests: the Bonferroni method, Bmj, vol.665, issue.6973, p.170, 1995.

R. W. Bottema, M. Kerkhof, . Reijmerink, . Ne, C. Thijs et al., CP, p.667

B. Brunekreef, . Van-oosterhout, . Aj, . Postma, . Ds et al., Gene-gene 668 interaction in regulatory T-cell function in atopy and asthma development in 669 childhood, Journal of Allergy and Clinical Immunology, vol.126, issue.2, pp.338-346, 2010.

K. R. Bridges, . Barabino, . Gd, C. Brugnara, . Cho et al., , p.671

G. Bm, . De, . Guttmann, . Cr, J. Hofrichter et al., A multiparameter 672 analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy, Blood, vol.673, issue.12, pp.4701-4710, 1996.

M. S. Cai, . Li, and C. F. Zheng, Herpesviral infection and Toll-like receptor 2, Protein 675 & cell, vol.3, issue.8, pp.590-601, 2012.
DOI : 10.1007/s13238-012-2059-9

URL : https://link.springer.com/content/pdf/10.1007%2Fs13238-012-2059-9.pdf

J. L. Casanova, L. Abel, and L. Quintana-murci, Human TLRs and IL-1Rs in host defense: 677 natural insights from evolutionary, epidemiological, and clinical genetics, Annual 678 review of immunology, vol.29, pp.447-491, 2011.
DOI : 10.1146/annurev-immunol-030409-101335

J. Chen, . Ng, . Mml, and J. Chu, Activation of TLR2 and TLR6 by dengue NS1 protein 680 and its implications in the immunopathogenesis of dengue virus infection, Pathog, vol.681, issue.7, p.1005053, 2015.

Y. C. Chen, . Hsiao, . Cc, . Chen, . Cj et al., , p.683

Y. H. Wang and L. Mc-(, Toll-like receptor 2 gene polymorphisms, pulmonary 684 tuberculosis, and natural killer cell counts, BMC medical genetics, vol.11, issue.1, p.17, 2010.

A. Coelho, A. Dias, A. Morais, B. Nunes, E. Ferreira et al., Genetic variation in CD36, HBA, NOS3 and VCAM1 is associated with chronic 687 haemolysis level in sickle cell anaemia: a longitudinal study, European journal of 688 haematology, vol.92, issue.3, pp.237-243, 2014.

L. De-oliviera-nascimento, P. Massari, and L. M. Wetzler, The role of TLR2 in infection and 690 immunity, Frontiers in immunology, vol.3, p.79, 2012.

A. Driss, . Asare, . Ko, J. M. Hibbert, . Gee et al., Sickle cell 692 disease in the post genomic era: a monogenic disease with a polygenic phenotype, 2009.

, Genomics insights, vol.2, p.23

W. Eder, W. Klimecki, L. Yu, V. Mutius, E. Riedler et al., , p.695

F. D. Martinez and A. Study-team, Toll-like receptor 2 as a major gene for 696 asthma in children of European farmers, Journal of allergy and clinical immunology, vol.697, issue.3, pp.482-488, 2004.

S. H. Embury, . Clark, . Mr, G. Monroy, and N. Mohandas, Concurrent sickle cell anemia and 699 alpha-thalassemia. Effect on pathological properties of sickle erythrocytes, Journal of 700 Clinical Investigation, vol.73, issue.1, p.116, 1984.

S. Esposito, A. Zampiero, L. Pugni, S. Tabano, C. Pelucchi et al., , p.702

M. Miozzo, F. Mosca, and N. (. Principi, Genetic polymorphisms and sepsis in 703 premature neonates, PloS one, vol.9, issue.7, p.101248, 2014.

M. Folwaczny, J. Glas, L. Tonenchi, . Török, and . Hp, Microsatellite GT polymorphism in 705 intron 2 of human Toll-like receptor (TLR) 2 gene and susceptibility to periodontitis, 2011.

, Clinical oral investigations, vol.15, issue.3, pp.435-441

J. A. Greene, N. Sam-agudu, . John, . Cc, . Opoka et al., , 2012.

, Toll-like receptor polymorphisms and cerebral malaria: TLR2 ?22 polymorphism is 709 associated with protection from cerebral malaria in a case control study, Malaria 710 journal, vol.11, issue.1, p.47

T. R. Hawn, D. Scholes, ,. Li, . Ss, H. Wang et al., , p.712

A. Aderem, . Stamm, . We, . Zhao, and . Lp, Toll-like receptor polymorphisms and 713 susceptibility to urinary tract infections in adult women, PloS one, vol.4, issue.6, p.5990, 2009.

J. C. Hernandez, . Giraldo, . Dm, S. Paul, and S. Urcuqui-inchima, Involvement of neutrophil 715 hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 716 protection, PloS one, vol.10, issue.3, p.119844, 2015.

S. Hippenstiel, B. Opitz, B. Schmeck, and N. (. Suttorp, Lung epithelium as a sentinel and 718 effector system in pneumonia-molecular mechanisms of pathogen recognition and 719 signal transduction, Respiratory research, vol.7, issue.1, p.97, 2006.

A. Hishida, K. Matsuo, Y. Goto, M. Naito, K. Wakai et al., No 721 associations of Toll-like receptor 2 (TLR2)-196 to-174del polymorphism with the risk of 722, 2010.

, Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese

, Gastric Cancer, vol.13, issue.4, pp.251-257

M. Ioana, B. Ferwerda, . Plantinga, . Ts, M. Stappers et al.,

F. Burada, N. Panduru, . Sauerwein, and O. Doumbo, immunity, vol.80, issue.5, pp.1917-1922, 2012.

D. K. Kaul, . Fabry, . Me, . Nagel, and . Rl, The pathophysiology of vascular obstruction in the 729 sickle syndromes, Blood reviews, vol.10, issue.1, pp.29-44, 1996.

T. Kawai, A. , and S. (. , Pathogen recognition with Toll-like receptors. Current opinion in 731 immunology, vol.17, pp.338-344, 2005.

T. Kawai, A. , and S. (. , Toll-like receptors and their crosstalk with other innate receptors in 733 infection and immunity, Immunity, vol.34, issue.5, pp.637-650, 2011.

M. Kerkhof, . Postma, . Ds, B. Brunekreef, . Reijmerink et al., JC, p.735

U. Gehring and G. (. Koppelman, Toll-like receptor 2 and 4 genes influence 736 susceptibility to adverse effects of traffic-related air pollution on childhood asthma, 2010.

, Thorax, vol.65, issue.8, pp.690-697

E. M. Klaassen, . Thönissen, . Be, G. Van-eys, E. Dompeling et al., A systematic 739 review of CD14 and toll-like receptors in relation to asthma in Caucasian children, 2013.

, Asthma & Clinical Immunology, vol.9, issue.1, p.10

M. S. Kormann, M. Depner, D. Hartl, N. Klopp, T. Illig et al., , p.742

V. Sk, E. Mutius, and M. Kabesch, Toll-like receptor heterodimer variants protect 743 from childhood asthma, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.86-92, 2008.

E. Y. Lee, J. J. Yim, . Lee, . Hs, . Lee et al., Dinucleotide repeat 745 polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to 746 rheumatoid arthritis, International journal of immunogenetics, vol.33, issue.3, pp.211-215, 2006.

Y. T. Lin, A. Verma, and . Hodgkinson, C(2012) Toll-like receptors and human disease: lessons 748 from single nucleotide polymorphisms, Current genomics, vol.13, issue.8, pp.633-645

S. Y. Liu, . Sanchez, . Dj, and G. (. Cheng, New developments in the induction and antiviral 750 effectors of type I interferon, Current opinion in immunology, vol.23, issue.1, pp.57-64, 2011.

X. Ma, Y. Liu, . Gowen, . Bb, . Graviss et al., Full-exon 752 resequencing reveals toll-like receptor variants contribute to human susceptibility to 753 tuberculosis disease, PloS one, vol.2, issue.12, p.1318, 2007.

Y. Ma and . He, Recognition of herpes simplex viruses: toll-like receptors and beyond, Journal of molecular biology, vol.755, issue.6, pp.1133-1147, 2014.

A. E. Medvedev, Toll-like receptor polymorphisms, inflammatory and infectious 757 diseases, allergies, and cancer, Journal of Interferon & Cytokine Research, vol.33, issue.9, p.467, 2013.

K. Miedema, W. Tissing, T. Poele, E. M. Kamps, . Wa et al.,

J. C. Jongste, H. A. Smit, D. Pagter, . Ap, M. Bierings et al., HM(2012) lymphoblastic leukemia and atopic disease, Leukemia, vol.26, issue.6, p.1210

E. A. Misch, . Hawn, and . Tr, Toll-like receptor polymorphisms and susceptibility to human 765 disease, Clinical Science, vol.114, issue.5, pp.347-360, 2008.

B. P. Mmbando, J. Mgaya, . Cox, . Se, . Mtatiro et al., , p.767

R. W. Snow, N. Jeffries, . Geller, and . Nl, Negative Epistasis between sickle and foetal 768 haemoglobin suggests a reduction in protection against malaria, PloS one, vol.10, issue.5, p.769, 2015.

S. Mukherjee, D. Ganguli, and . Majumder, Global footprints of purifying selection on 771 toll-like receptor genes primarily associated with response to bacterial infections in 772 humans, Genome biology and evolution, vol.6, issue.3, pp.551-558, 2014.

H. D. Nischalke, C. Berger, K. Aldenhoff, L. Thyssen, M. Gentemann et al., , p.774

F. Lammert, J. Nattermann, T. Sauerbruch, U. Spengler, and B. Appenrodt, Toll-like 775 receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased 776 risk for spontaneous bacterial peritonitis in liver cirrhosis, Journal of hepatology, vol.55, issue.5, pp.777-1010, 2011.

H. D. Nischalke, M. Coenen, C. Berger, K. Aldenhoff, T. Müller et al., , p.779

C. Odenthal, M. Schulze, F. Grünhage, and F. (. , The toll-like receptor, vol.2, pp.2-196, 2012.

, 174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular 781 carcinoma in chronic hepatitis C, International journal of cancer, vol.130, issue.6, pp.1470-1475

E. Noguchi, F. Nishimura, H. Fukai, J. Kim, K. Ichikawa et al., An 783 association study of asthma and total serum immunoglobin E levels for Toll-like 784 receptor polymorphisms in a Japanese population, Clinical & Experimental Allergy, vol.785, issue.2, pp.177-183, 2004.

M. Nouraie, . Lee, . Js, Y. Zhang, T. Kanias et al., , p.787

J. Gibbs, . Hildesheim, and . Me, The relationship between the severity of 788 hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell 789 anemia in the US and Europe, Haematologica, vol.98, issue.3, pp.464-472, 2013.

C. L. Novis, . Archin, . Nm, . Buzon, . Mj et al., , p.791

V. Planelles and A. Bosque, Reactivation of latent HIV-1 in central memory CD4+ T 792 cells through TLR-1/2 stimulation, >1. The only 900 originally binary trait was (B), vol.10, 2013.

. Purcell, Using the open-source whole genome association analysis toolset PLINK v1, vol.07, 2007.

. Cochran-armitage-trend and . Test, TREND) and five genotypic tests including the Additive test, 904 measuring additive effects of allele dosage (ADD), Genotypic (2 df) test (GEN)

, Only those results for which the chi-squared test was applicable are shown

, Abbreviations: SCA, sickle cell anemia

, The reference group for the allelic model was allele A. The reference group for -? 3.7 thalessemia was the absence of -? 3.7 thalassemia. For the fetal hemoglobin there was no reference group. For steady state hemoglobin there was no reference group

, Fetal hemoglobin (%)

, Steady state hemoglobin (g/dL)

, The Bonferroni adjusted ? = 0.001667, where the number of tests performed per inheritance model per locus n = 30

R. C. Team, Note 1: The interactions between factors were tested but because they were not statistically significant they were not included in the final model, 2013.

:. Abreviations and . S. Sca, Standard Error; CI, Confidence interval. there was no reference group. The reference group for -? 3.7 thalessemia was the absence of -? 3.7 thalassemia. The reference group for the HBB*S haplotype, The reference group for male gender was female gender

, Hemolytic component per score unit

, Fetal hemoglobin (%)

, The Bonferroni adjusted ? = 0.001471, where the number of tests performed per inheritance model per locus n = 34

R. C. Team, Note 1: The interactions between factors were tested but because they were not statistically significant they were not included in the final model, 2013.

, Abreviations: SCA, sickle cell anemia

S. E. , Standard Error

, Confidence interval; Indel, insertion or deletion variation

, Del, deletion; Ins, insertion